Inspire Medical Systems, Inc. Announces Third Quarter 2020 Financial Results and Updates 2020 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Inspire Medical Systems (INSP) Tops Q3 EPS by 33c, Revenues Beat; Raises FY20 Revenue Guidance Above Consensus
November 2, 2020 5:01 PM ESTInspire Medical Systems (NYSE: INSP) reported Q3 EPS of ($0.39), $0.33 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $35.8 million versus the consensus estimate of $22.75 million.
Recent Business Highlights
Generated revenue of $35.8 million in the third quarter of 2020, a 72% increase over the same quarter last yearReported gross margin of 85.5% in the third quarter of 2020, an increase over the 83.4% reported in the same quarter last yearActivated 42 new centers in the third quarter of 2020, bringing the total to 370 U.S. medical centers implanting Inspire therapyCreated... More